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Background: Cough, the most important airways defensive mechanism is modulated by many afferent inputs
either from respiratory tussigenic areas, but also by afferent drive from other organs. In animal models, modulation
of cough by nasal afferent inputs can either facilitate or inhibit the cough response, depending on the type of
trigeminal afferents stimulated.
Methods: In this study we addressed the question of possible bidirectional modulation of cough response in
human healthy volunteers by nasal challenges with TRPA1 and TRPM8 agonists respectively. After nasal challenges
with isocyanate (AITC), cinnamaldehyde, (−) menthol and (+) menthol (all 10-3 M) nasal symptom score, cough
threshold (C2), urge to cough (Cu) and cumulative cough response were measured).
Results: Nasal challenges with TRPA1 relevant agonists induced considerable nasal symptoms, significantly
enhanced urge to cough (p<0.05) but no statistically significant modulation of the C2 and cumulative cough
response. In contrast, both TRPM8 agonists administered to the nose significantly modulated all parameters
including C2 (p<0.05), Cu (p<0.01) and cumulative cough response (p <0.01) documenting strong anti irritating
potential of menthol isomers.
Conclusions: In addition to trigeminal afferents expressing TRP channels, olfactory nerve endings, trigemino –
olfactoric relationships, the smell perception process and other supramedullar influences should be considered as
potential modulators of the cough response in humans.
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The cough reflex is not a static phenomenon, but is a
flexible entity modulated by many central and peripheral
neuronal mechanisms, sometimes termed ‘cough plasti-
city’ [1]. Stimulation of trigeminal terminals in the nose
by the TRPV1 agonist capsaicin, and histamine signifi-
cantly enhances cough response induced in laboratory
animals. Such stimulation also up regulates cough
responsiveness in human healthy subjects and patients
with allergic rhinitis [2-5]. These findings suggest cough
is enhanced by increased afferent drive form the nose to* Correspondence: jplevkova@gmail.com
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reproduction in any medium, provided the orthe sensory trigeminal nuclei and then by cooperation
with the brainstem neuronal circuits modulating
cough. Nucleus tractus solitarius (nTS) is believed to
be the site important for modulation of cough reflex
at the central level [6]. Naturally, if noxious substance
enter the airways through the nose, then defensive
mechanisms in this region should be up regulated
and prepared for airway protection.
Recently we studied the mechanism underlying the
antitussive action of menthol, which is frequently used
in many over–the–counter preparations for cold and
cough treatments, the majority of which are made for
nasal application (drops, sprays). Despite their frequent
use and recognised antitussive action [7,8] the exact
mechanism of menthol action had not been elucidated.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anaesthetized guinea pigs, and using single cell RT PCR
method we suppose that antitussive action of menthol is
mediated by nasal trigeminal afferents, more accurately by
subpopulation of TRPV1-/TRPM8+ expressing neurons
[9]. We are aware of species differences, but guinea pig is
an ideal model to study cough because the neuro-
physiology and neuropharmacology of airway afferents
are very similar to the human condition.
Taken together, cough seems to be both up regulated
and down regulated by distinct populations of nasal
afferents. Signalling from nociceptors may primarily up
regulate cough, whereas activation of other nasal noci-
ceptors may down regulate it. To test this hypothesis we
employed nasal nociceptive stimulation by TRPA1
ligands and nasal menthol challenges to observe whether
and how it does influence the cough responsiveness in
humans. Nasal nociceptive stimulation was performed
by TRPA1 agonists allyl-isothiocyanate (AITC) and cin-
namaldehyde which actually may represent a model for
air-born irritants induced signalling [10]. The broad
spectrum of irritants like acrolein, isocyanates, oxidizing
substances and other pollutants activate the cation chan-
nel TRPA1 by covalent modification of the channel pro-
tein [11,12]. Activation of this channel leads to a
sensation of airway irritation [13]. TRPA1 agonists have
been identified as potent tussive stimuli in animal mod-
els and humans and provide a promising evidence to
suggest TRPA1 as a relevant antitussive targets with pos-
sible clinical applications [14,15]. Nasal trigeminal
TRPA1 as well as TRPM8 stimulation had never been
studied regarding modulation of the cough reflex in
humans.
Aim of the study
The aim of the present study was to assess the cough
responsiveness in healthy human volunteers after
intranasal challenges of TRPA1 agonists AITC and




The study population consisted of 20 volunteers for
TRPA1 relevant challenges and 18 volunteers for
TRPM8 relevant challenges (equal gender distribution,
average age 23 yrs, non-smokers, non atopic, with nor-
mal lung functions tests, anterior rhinoscopy, and with-
out acute respiratory infection in preceding 4 weeks).
Based on structured interviewer-led questionnaire, each
subject was asked about respiratory symptoms and his/
her individual and family history of bronchial asthma,
allergic rhinitis, gastroesophageal reflux, cardiovascular
diseases and ACE inhibitor treatment. After review oflung function tests, ear-nose-throat examination and
questionnaire, the subjects were considered as meeting
(or not) inclusion criteria for the study.
The study was approved by the Committee for Ethics
of the Jessenius Faculty of Medicine in Martin. Informed
consent was obtained from all study subjects. However,
the information on study endpoints given to subjects
was limited to minimise potential conscious influence by
participants on cough and urge to cough.
Assessment of cough sensitivity (CS)
Cough sensitivity testing was performed according to ERS
Cough Taskforce recommendations [16]. Capsaicin
(30.5 mg) was dissolved in 1 ml of pure ethanol and 1 ml
of polyoxyethylene sorbitan (Tween 80) and then further
dissolved in 8 ml of normal saline to yield a 0.01 M stock
solution. The solution was diluted with saline in order to
obtain serial doubling concentrations ranging 0.49–
1,000 μM all freshly made the day of testing. In order to
increase cough challenge blindness, inhalations of saline
(placebo) was randomly interspersed between incremental
concentrations of capsaicin. This strategy is used to reduce
the effects of voluntary suppression or conditioned
responses in subjects who would otherwise be anticipating
progressively higher concentrations of tussive agent [16].
Each subject tested had performed lung function tests
and inhalation of saline aerosol before increasing
concentrations of aerosols of capsaicin solutions were
applied. Aerosols were produced by computer assisted
compressed air driven nebulizer Koko Digi Doser with
controlled nebulizer output per breath. The lowest con-
centrations of capsaicin induced two or more coughs
(C2) and five or more coughs (C5) were determined,
log transformed and the dose response curves of the
total number of coughs were constructed. According to
the ERS recommendations, only coughs that appeared
immediately after aerosol inhalation had been counted.
Subjects were simultaneously asked to subjectively
evaluate the urge to cough based on their “perceived”
airway irritation after capsaicin inhalation until they
reached C2.
Assessment of urge to cough
Urge to cough is defined as the sensation of airway irri-
tation that precedes the motor act of cough. This urge
to cough phenomenon represents the cortical neural
contribution to the airway defence system [17]. However,
it is difficult to measure it accurately, because it is an ex-
clusively subjective phenomenon. We used the method
described by Dicpinigaitis et al. [18], we estimated Cu -
the first concentration of capsaicin aerosol which
induced urge to cough, and we asked our subjects to
evaluate and compare verbally the feelings regarding the
urge to cough after each capsaicin inhalation.
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The subject0s head was tilted carefully on one side and
using a micropipette 20 μl of the particular agonists or
(saline)/vehicle, respectively, had been applied into the
nostril of the contralateral side, approximately 1.5 – 2 cm
from the external orifice. The same manner was used
for application of agonists into contralateral nostril. The
external surface of the nose was gently massaged for a
few seconds to spread instilled volume on a larger part
of the nasal mucosa. 1% DMSO was used as the univer-
sal vehicle for all of delivered apolar substances. Stock
solutions of AITC (10-1 M, Sigma) and cinnamaldehyde
(10-1 M, Sigma) in 1% DMSO, had been further diluted
in saline (to 10-3 M) every day prior the challenges. (+)
menthol and (−) menthol (both Sigma) as polar alcohols,
were diluted in ethanol to stock (10-1 M) and further
diluted in saline (to 10-3 M) at the day of the challenges,
as well. It is known that ethanol may potentiate cough
reflex as it was documented in guinea pigs and humans
already, but in our study final concentration of ethanol
applied onto the nasal mucosa was 0.5%.
Nasal symptoms
We have used previously modified scoring system to as-
sess intensity of nasal symptoms. However in present
protocols subjects never sneezed after nasal challenges,
they only reported burning and unpleasant olfactory sen-
sation after nasal AITC, slight burning only after cinna-
maldehyde. Intranasal menthol challenges did not
induce subjective feeling that may be described as
“symptoms” or unpleasant sensations, only cooling.
Therefore we decided to evaluate burning sensations
using modified scale from 0 to 10 (10 is the most inten-
sive burning the subject has ever experienced). Cooling
sensation after menthol challenges was determined simi-
larly. The amount of nasal secretions was also assessed
by means of weighing of used handkerchiefs (only for
AITC challenge, as other challenges did not provoke
considerable rhinorrhoea).
Data analysis
Capsaicin cough thresholds C2, C5, and urge to cough
are expressed as geometric mean with 95% confidence
interval. The total numbers of coughs for the dose re-
sponse curves are presented as mean and standard error
of mean. For the statistical analysis repeated measures
ANOVA and Friedman’s test as appropriate were
employed using statistical programme GraphPad InStat.
The differences were considered significant at p < 0.05.
Study protocol
Subjects took nasal challenges with subsequent cough
sensitivity testing once a week same time of the day. Prior
to this, they underwent general medical examination,lung function testing, and ear-nose-throat examination.
Cough sensitivity was determined in volunteers after nasal
saline challenge first, and later after intranasal vehicle,
intranasal AITC (10-3 M) cinnamaldehyde (10-3 M) for
TRPA1 arm of the study. The same pattern was applied
for TRPM8 arm of the study; capsaicin cough tests were
performed after nasal saline, nasal vehicle, (−) menthol
(10-3 M) and (+) menthol (10-3 M) (dissolved in ethanol
and further diluted in saline). Challenges were performed
in randomized order, except the first one challenge
after nasal saline, which was fixed. Randomization
was used to minimize the startle reaction which has




Administration of isocyanate and cinnamaldehyde
induced burning sensation when topically applied onto
the nasal mucosa. Administration of isocyanate also
induced lacrimation and eye irritation. Subjects described
strong irritation and burning accompanied by horseradish
or wasabi smell immediately after the challenge. However,
this burning suddenly and rapidly minimized, while appli-
cation of even lower concentrations of capsaicin [3]
induced burning with the intensity 7–8 at 10 point scale
lasting for more than 20 minutes (Figure 1). Application
of cinnamaldehyde induced only negligible burning and
subjects reported the smell sensation of cinnamon to be
more intense then burning. Application of (−) and (+)
menthol induced no burning, but a cooling sensation in
all subjects.
Regarding other nasal symptoms, only nasal isocyanate
induced measurable discharge (secretion), but other
stimuli failed to induce any considerable symptoms in-
cluding nasal mucosal swelling or discharge.
Similarly, all nasal challenges induced no significant
changes in airway expiratory flows (nasobronchial reflex –
narrowing of airway lumen by nasal stimulation). No
considerable drop of FEV1 or FVC was detected after
nasal TRPA1 and TRPM8 relevant challenges (Table 1).
Cough reflex sensitivity and cumulative cough count for
TRPA1 line
Data obtained for C2 and C5 were shifted from baseline
and vehicle values, however, difference did not reach
statistical significance. The only parameter which was sig-
nificantly influenced was urge-to-cough after intranasal
isocyanate challenge (Table 2 and Figure 2).
Cumulative cough response obtained during the cough
tests after nasal isocyanate and cinnamaldehyde challenges
do not differ significantly from baseline and vehicle values
(Figure 2). The total number of coughs obtained during






















Figure 1 Represents intensity of burning sensation induced by intranasal administration of AITC, and cinnamaldehyde (10-3 M) in
present study in comparison to burning induced by intranasal capsaicin 0.75 10-3 M (Plevkova et al., [5]). As it could be seen from the
trace, TRPA1 agonists are significantly less effective when comparing to TRPV1 agonist capsaicin. Thus we speculated that less effective trigeminal
drive was not enough to modulate cough response in our set up, *p<0.05.
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respectively (all p>0.05). Also regression analyses did not
show significant differences.
Cough reflex sensitivity and cumulative cough count for
TRPM8 line
Menthol nasal challenges decreased cough sensitivity
demonstrated by higher C2 capsaicin concentrations
(Table 3; Figure 3) compared to the baseline and vehicle
data (both p<0.05).
Cumulative cough counts after nasal (+) and (−) men-
thol challenges (12.2 and 14.1 coughs, respectively) were
lower compared to the saline and vehicle values (19.1
and 18.7 coughs; both p < 0.01). Regression analysis
showed similar differences.
Assessment of urge to cough and subjective sensations
after nasal challenges
The lowest concentration of capsaicin that induced an
urge to cough was estimated based on study participants’
subjective evaluation during the capsaicin test after par-
ticular nasal challenges. Nasal TRPA1 agonist isocyanate
challenge induced a “very unpleasant” sensation, bring-
ing negative emotional assessment to this challenge.Table 1 Values of FEV1/FVC after intranasal challenges with s
expressed as % of predicted
TRPA1 line Saline Vehicle
mean ± SD 99.2 ± 0.06% 97.7% ± 0.0
TRPM8 line saline vehicle
mean ± SD 99.6% ± 0.08 98.1% ± 0.0
Note: data are expressed as % of predicted values.Otherwise cinnamaldehyde nasal challenge was evaluated
by most subjects as being “not bad” with mainly olfactory
sensation of cinnamon. No adverse reaction but ra-
ther a very short mild burning of nasal mucosa at the
moment of the challenge was generally reported. In
two subjects nasal cinnamaldehyde induced attack of
migraine 1 hour after the challenges. Urge to cough
after nasal AITC occurred at lower capsaicin concen-
trations (Figure 2, Table 2) and subjects reported
subjectively considerable airway irritation. Urge to
cough after cinnamaldehyde was not influenced
significantly (Table 2).
Menthol nasal challenges produced in subjects refresh-
ing feeling and cooling sensation. Similarly to the cough
threshold, urge to cough was shifted to higher capsaicin
concentrations. Subjects reported that menthol in the
nose made capsaicin airway irritation less intense, and
subjectively they tolerated the capsaicin test better
(Table 3, Figure 3).
Discussion
Nasal challenges with (+) and (−) menthol (TRPM8
agonists) have beneficial effects in suppression of sub-
jectively evaluated airway irritation, increasing capsaicinaline, vehicles and both TRPA1 and TRPM8 agonists
AITC Cinnamaldehyde
7 98.4% ± 0.06 98.5% ± 0.06
(+) menthol (−) menthol
9 98.4% ± 0.06 99.8% ± 0.06
Table 2 Values of cough reflex sensitivity obtained in
TRPA1 line of the study
Saline Vehicle Isocyanate Cinnamaldehyde
C2
Cu 10.1 13.8 6.8 * 12.1
C2 GM 12.5 16.8 10.8 12.6
GSD 3.2 2.6 4.3 6.7
CI min 8.3 10.6 6.8 7.5
CI max 15.7 17.2 12.8 13.7
C5
GM 198.4 183.7 277.4 287.1
GSD 4.4 4.8 4.3 3.46
CI min 196.4 181.6 148.4 166.5
CI max 200.4 185.8 518.4 495.36
Note: data are expressed in μM, GM – geometric mean, GSD – geometric
standard deviation, CI min, CI max – 95% confidence intervals with alpha =
0.05. *p<0.05, Cu – urge to cough, C2 – concentration of capsaicin inducing 2
or more coughs, C5 - concentration of capsaicin inducing 5 or more coughs.
Table 3 Values of cough reflex sensitivity obtained in
TRPM8 line of the study
Saline Vehicle (+) Menthol (−) Menthol
C2
Cu 11.8 12.7 26.5 * 22.4*
C2 GM 12.5 14.7 31.3 * 26.3*
GSD 4.6 2.7 5.9 6.1
CI min 10.4 11.3 28.9 23.8
CI max 14.7 17.2 33.6 28.7
C5
GM 261 249 458.5 478.8
GSD 4 4.3 3.1 2.9
CI min 259 248 456.8 477
CI max 263 251 460.2 480.5
Note: data are expressed in μM, GM – geometric mean, GSD – geometric
standard deviation, CI min, CI max – 95% confidence intervals with alpha =
0.05. *p<0.05, Cu – urge to cough, C2 – concentration of capsaicin inducing 2
or more coughs, C5 concentration of capsaicin inducing 5 or more coughs.
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On the other hand expected enhancement of cough due
to activation of TRPA1 by nasal isocyanate and cinna-
maldehyde was not observed.
This study assessed the modulation of cough response
induced by nasal stimulation of TRPA1 and TRPM8
channels. TRPA1 is the channel most likely stimulated
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Figure 2 Upper panel represents the changes of cough threshold - pa
different when comparing data obtained after nasal saline, vehicle, AITC an
during the cough tests after nasal AITC and cinnamaldehyde do not differendogenous inflammatory products and is categorized
as nociceptive. It is responsible for induction of
burning, irritation and pain [12]. TRPM8 channel is
mainly thermoreceptor with activation threshold
around 24°C, giving the feeling of innocuous cold
and freshness. It could also be activated by menthol
[13,14] which is known to have contra irritating
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Figure 3 Menthol nasal challenges decreased cough sensitivity, what is demonstrated by the higher capsaicin concentrations for the
cough threshold C2 (upper panel) compared to the data obtained after nasal vehicle and saline data (both isomers p<0.05 for C2).
Cumulative cough counts and total cough response after nasal (+) and (−) menthol challenges decreased significantly compared to the saline
and vehicle values p< 0.01. Regression analysis showed similar differences *p<0.05, **p<0.01.
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awake and anaesthetized guinea pigs [9]. The main tar-
gets for menthol action in the airways are the trigeminal
afferents which are distributed widely in the nasal mu-
cosa. More than 60% or nasal trigeminal afferents ex-
press TRPM8 channel, some of those afferents are
TRPV1-/TRPM8+ [9] and expression of TRPM8 in nod-
ose and jugular neurons innervating lower airways was
less frequent. We propose, that these terminals, which
are not nociceptors (as are TRPV1-) may be involved in
the down regulating cough observed by nasal menthol
application in guinea pigs. Animal models for cough
studies and the results obtained in guinea pig models
cannot be conclusively applied to the clinical conditions.
Although the guinea pig vagus nerve pharmacology and
physiology is very similar to human vagus nerve, these
results should always be considered and interpreted with
caveats [16]. In the present study in human volunteers,
menthol was delivered only to the nose (using a micro-
pipette). It is believed that this nasal challenge [3,19]
minimizes leaking of menthol deeper into the airways.
Although the menthol is highly volatile substance, the
possibility for further movement of menthol vapours
could not be completely excluded. Further we would
suggest that these minimal amounts of menthol (ifpresent) in lower airways would be insufficient to modu-
late cough reflex.
Studies estimating the effect of menthol on cough re-
flex in humans are conflicting. Morice and colleages
reported antitussive effect of menthol vapours after oral
inhalation [7]. However, recent studies document no ef-
fect of inhaled (−) menthol on the cough reflex in chil-
dren [20] or patients prior bronchoscopy [21]. We think
that effect of menthol in our study and also in the study
by Morice et al. is local, influencing airway afferents
involved in modulation of cough reflex.
It is also possibile that systemic exposure of lung and
airway afferents to the menthol reabsorbed from nasal
musoca is responsible for the observed effect. It was
identified that TRPM8 nerve fibres are abundant in nasal
mucosa particularly around blood vessels, and may me-
diate neurovascular reflexes [22]. Johnson et al. in 2009
[23] reported that menthol is involved in regulation of
vascular tone, and it may be responsible for vasodilata-
tion. This mechanism together with the abundance of
nasal mucosal vasculature may be responsible for sys-
temic absorption of menthol with subsequent influence
on lung and airway afferents. However we did not
measure the serum concentration of menthol after ad-
ministration of nasal drops. A study of transdermal
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application of patch by Martin & Valdes, reported de-
tectable but very low plasma concentrations of menthol.
As menthol has an antitussive effect after oral adminis-
tration in guinea pigs in a dose 100 mg/kg of body
weight (Brendan Canning, unpublished data), vapors
entering the nose after oral administration and the sys-
temic effects need to be considered.
Our controlled study shows that nasal menthol chal-
lenge in humans suppresses cough reflex induced by in-
halation of capsaicin. Moreover, menthol can stimulate
not only trigeminal but also olfactory terminals and acti-
vate cortical voluntary cough related pathways. This
complex action of menthol brings cooling and freshness
sensations, and reduces dyspnoea and respiratory drive
perception [24] possibly with typical mint smell. Men-
thol also decreases trigeminal sensitivity to irritants [25].
Both molecules of menthol isomers (+) and (−) were
effective equally, but subjects tolerated (+) menthol
challenge better. Subjects were blinded to the substances
(+ and – menthol) during the challenge, however, ques-
tioning them after the testing they considered (+) menthol
more pleasant compared to (−) menthol, which mimicked
over the counter drug smell.
Cough is modulated by the cortical influences [26]
and many other factors including behavioural, atten-
tional or cognitive may also modulate cough response
[27]. We speculate that subjectively pleasant sensa-
tions may inhibit the urge to cough by the cortical
mechanism, whereas unpleasant sensations may en-
hance it.
We expected that nasal challenges with TRPA1 ago-
nists would enhance cough response similarly as it does
TRPV1 agonist capsaicin challenge in animals and
humans [2,3]. Obviously, our data show that cough
modulation via nasal TRPA1 is less intensive than that
after TRPV1 agonist challenge. Activation of TRPA1
induces symptoms (e.g. burning) to 1/3 of those induced
by equal concentration of agonists for TRPV1 (Figure 1).
Afferent nociceptive drive induced by nasal capsaicin
challenge was 7/10 on the VAS and considerable burning
lasted up to 15–20 min. In present subjects (with nasal
TRPA1 agonists) burning or unpleasant sensations
reached 5/10 and disappeared after 2–3 minutes. It is
possible that higher concentrations of isocyanate or cin-
namaldehyde, repeated challenges, or challenges in sub-
jects with trigeminal sensorineural hyperresponsiveness
might modulate cough parameters. It had been docu-
mented that TRPA1 agonists induce cough in guinea
pigs and humans after they are inhaled into the lower
airways [14]. The C2 concentration was around 200 mM
of cinammaldehyde. For nasal challenges in mice 1%
toluene diisocyanate had been used by Taylor Clark et al.
[28]. All of these studies proved a strong irritation effectof TRPA1 activating substances. However, naturally
present irritants, either indoor, or outdoor, are present
in inhaled air in very low concentrations. Thus, we used
the lowest concentrations capable to induce sensory acti-
vation to mimic situation of natural exposure to air born
irritants. In pre tests we identified appropriate concen-
trations for given agonists at 10-3 M, which was quite
well tolerated, but induced nasal symptoms.
In addition, nasal challenge with isocyanate in our ex-
perimental set up modulated the urge to cough. We as-
sume that perception of airway irritation induced by
nasal AITC challenge could interfere with the irritation
induced by the inhalation of capsaicin itself during the
cough test. Subjects already reached the concentration
for urge to cough, so they were conscious of the airway
irritation and unpleasant sensations possibly leading to
cough long before they reached the C2. Early presence
of urge to cough during the capsaicin test after nasal iso-
cyanate documented the nociceptive capabilities of nasal
TRPA1 agonists by possibly enhancing afferent drive
induced by the capsaicin inhalation. In contrast, nasal
TRPM8 agonists reduced the urge to cough. After men-
thol nasal challenge subjects tolerated the capsaicin test
much better, the urge to cough that proceed the
cough motor act was detected later, close to C2 con-
centration. We documented coughs that had not been
preceded by the urge to cough at all after nasal men-
thol pre-treatment in approximately 40% out of tests.
Such coughs might have very much simple reflex ori-
gin without cortically processed urge to cough
induced phenomena.
We mentioned possible trigeminal - olfactory inter-
action in modulation of cough response in our interpre-
taion of the observed menthol effects. The nature and
extent of interactions between trigeminal and olfactory
stimulation are poorly understood however TRPM8 and
TRPA1 were detected both on trigeminal and olfactory
nerve terminals [29]. Exposure of the nose to the malo-
dorants (unpleasant smells) increases the responsiveness
of trigeminal nerves, and this mechanism is mediated by
paracrine signalling pathway between olfactory and tri-
geminal nerves [30]. Patients with acquired olfactory loss
exhibit reduced trigeminal sensitivity, possibly due to the
lack of these interactions. Considering possible modula-
tion of cough by cortical activity induced by odours is a
phenomenon that could contribute to the antitussive ef-
ficiency of placebo [31]. In addition, the sweet taste of
cough syrups or honey may have modulatory roles
through oral/oropharyngeal receptors.
However, the specific role of particular channels in any
biological process can only be conclusively proven by
the use of selective channel antagonists, which at the
moment, are not available for human use in clinical con-
ditions [32]. The results we have obtained in our studies
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significantly modulates urge to cough probably via add-
itional airway irritation instead of capsaicin test itself.
Both TRPA1 agonists failed to modulate cough threshold
and total cough response at these concentrations, sug-
gesting that higher concentration or repeated exposure
to them are necessary to modulate cough response. Both
menthol isomers after nasal administration significantly
modulated urge to cough, cough threshold, and total
cough response probably via the reduction of airway irri-
tation induced during capsaicin challenge. In addition to
trigeminal afferents expressing TRP channels, olfactory
nerve endings, trigemino – olfactoric relationships,
smell perception process and other supramedullar influ-
ences should be considered as having potential to
modulate the cough response in humans [33].
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